Hokkaido, Japan

Masami Ashida

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nb Health Laboratory Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masami Ashida. Retrieved from https://idiyas.com/inventor/masami-ashida-4ecexrv4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masami Ashida: Innovator in Antibody Research

Introduction

Masami Ashida is a notable inventor based in Hokkaido, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and related pharmaceutical applications. His work has the potential to impact various medical treatments and research.

Latest Patents

Masami Ashida holds a patent for an invention titled "Antibody, Nucleic Acid, Cell, and Pharmaceutical." This patent represents a crucial advancement in the understanding and application of antibodies in therapeutic contexts. He has 1 patent to his name, showcasing his innovative contributions to the field.

Career Highlights

Ashida is currently associated with Nb Health Laboratory Co., Ltd., where he continues to engage in groundbreaking research. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing the impact of his work.

Collaborations

Among his coworkers are Megumi Hikichi and Miki Nakagawa, who contribute to the collaborative environment at Nb Health Laboratory Co., Ltd. Their combined expertise fosters innovation and drives the research initiatives forward.

Conclusion

Masami Ashida's work in antibody research exemplifies the spirit of innovation in biotechnology. His contributions are paving the way for advancements in medical treatments and research applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…